InQpharm’s leading weight management product, Liposinol™ is a clinically-proven organic fat binder for general weight management, treatment and prevention of obesity. Launched in 2006, this unique innovation was the first InQpharm product to achieve certification as a Class IIa medical device in Europe. It is sold in more than 40 countries and is the top-selling weight management product in Italy and Switzerland under our distribution partners’ brand names. Sales now exceed 250 million tablets to date.
Launched in four European markets in 2009, Liposinol™ with vitamins A, D and E was the first medical device fat binder with added vitamins to enter the market. With its clear competitive advantage it has been a great success and, embraced by our global distribution partners, it is now selling in over 14 European countries and is the top-selling weight management product, under our distribution partners’ brand names, in Belgium and France.
Another first to market with a medical device status is InQpharm’s ready-to-eat Liposinol™ with BerryLite. Launched in 2010, this product comes in a stick sachet. This fat binder is a powder that can be taken without water, while on the go.
Our latest innovation, Liposinol™ BerryLite with vitamins A, D and E, launched last year, combines the convenience of a ready-to-eat stick sachet with the nutritional benefits of added vitamins in an effective fat binder. This product is a perfect on-the-go weight management aid for busy lifestyles.
Liposinol™ effectively binds up to 26.6% of dietary fats and contains Litramine™ , a natural, patented fibre complex derived from 100% organic dehydrated leaves of a nutritious cactus which is rich in fibre. Known for its ability to bind fats, without any pharmacological action or effects on the human body, it has no known harmful side effects.
Liposinol™ is certified and manufactured according to the stringent quality-management system standard EN ISO 13485 for medical devices. The mechanical fat-binding action is the scientific basis for Liposinol™'s medical device licence in accordance with (MDD/93/42/EEC) for general weight management, prevention and treatment of obesity. This offers new and unique business opportunities with product claims approved EU-wide.
These three products are part of the BMIsmart™ range of weight management products tailored to help individuals achieve their own desired weight with a healthy Body Mass Index (BMI). Read about our other BMIsmart™ products, Appecal™, Glucosanol™ and Zenoctil™.